Log In
BCIQ
Print this Print this
 

M7824

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
DescriptionBi-functional immunotherapy
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today